Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $57.9300 (-0.09%) ($57.3200 - $58.1000) on Thu. Jun. 15, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.92% (three month average) | RSI | 42 | Latest Price | $57.9300(-0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.6% a day on average for past five trading days. | Weekly Trend | BAX declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(58%) SPLV(52%) VYM(52%) SPY(50%) XLP(50%) | Factors Impacting BAX price | BAX will decline at least -0.46% in a week (0% probabilities). TLT(-18%) VIXM(-16%) GDXJ(-9%) UUP(-5%) TIP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.46% (StdDev 0.92%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $58.64 | 5 Day Moving Average | $57.97(-0.07%) | 10 Day Moving Average | $58.74(-1.38%) | 20 Day Moving Average | $58.64(-1.21%) | To recent high | -3.5% | To recent low | 13.2% | Market Cap | $29.555b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |